The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
Exploring the Connection Between BDNF/TrkB and AC/cAMP/PKA/CREB Signaling Pathways: Potential for Neuroprotection and Therapeutic Targets for Neurological Disorders
Abstract
The BDNF/TrkB and AC/cAMP/PKA/CREB signaling pathways play a vital role in neuroplasticity, neuronal survival, and cognitive functions. This review explores its physiological and pathological implications in neurological disorders, with a focus on neurodegenerative diseases (NDDs) and neuropsychiatric disorders (NPDs). Neurological conditions increasingly burden public health, making understanding the biochemical mechanisms that underpin these diseases critical. BDNF, a neurotrophic factor, binds to the TrkB receptor, activating multiple intracellular signaling cascades that regulate cellular responses essential for neurogenesis, memory, and learning. Dysregulation within this pathway has been linked to various NDDs, as well as NPDs. Key components of the path, including adenylyl cyclase and cyclic AMP, mediate the effects of neurotransmitters and growth factors, influencing downstream targets like PKA and CREB, which are crucial for gene expression and synaptic changes. Furthermore, the review discusses the challenges of targeting this pathway for therapeutic interventions, including receptor isoform diversity, blood-brain barrier penetration, and potential side effects. Future strategies may include the development of selective TrkB modulators, nanoparticle carriers for drug delivery, and innovative gene therapy techniques. Advancing the understanding of this complex signaling network holds promise for effective interventions in treating neurological and psychiatric disorders, ultimately enhancing neuroprotection and cognitive resilience.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recombinant BDNF performs poorly in humans due to rapid degradation, limited brain penetration, and unstable exposure profiles [122,123,125].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [122]
Citations
Cites
1 retracted
Ullah, I., Badshah, H., Naseer, M. I., Lee, H. Y., & Kim, M. O. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8337-3 · Cited by 71
RetractedDomingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms
Citri, A., & Malenka, R. C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301559 · Cited by 2,323 · cited 1×
“The process is essential for the brain's adaptability, learning, and memory formation [140].”
Neurotrophin regulation of neural circuit development and function
Park, H., & Poo, M.-M. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3379 · Cited by 2,060
Purification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822
Brain-derived neurotrophic factor and its clinical Implications
Bathina, S., & Das, U. N. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.56342 · Cited by 1,381
BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity
Kowiański, P., Lietzau, G., Czuba, E., Waśkow, M., Steliga, A., & Moryś, J. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0510-4 · Cited by 1,359 · cited 3×
“The interaction of BDNF/TrkB/AC/cAMP/PKA/CREB forms a complex signaling network that contributes to synaptic plasticity, neuronal survival and differentiation, learning processes, and memory formation by regulating gene expression and fostering structural alterations at synapses [81, 137, 138].”
Inflammation in neurodegenerative diseases
Amor, S., Puentes, F., Baker, D., & Van Der Valk, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03225.x · Cited by 1,355
The global burden of neurological disorders: translating evidence into policy
Feigin, V. L., Vos, T., Nichols, E., Owolabi, M. O., Carroll, W. M., Dichgans, M., Deuschl, G., Parmar, P., Brainin, M., & Murray, C. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30411-9 · Cited by 1,303
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
Research works printed but not linked: 39
- Mukherjee R, Rana R, Mehan S, Khan Z, Das Gupta G, Narula AS et al (2025) Investigating the interplay between the Nrf2/Keap1/HO-1/SIRT-1 pathway and the p75NTR/PI3K/Akt/MAPK cascade in neurological disorders: mechanistic insights and therapeutic innovations. Molecular Neurobiology. Springer
- Carroll WM (2023) Evidence Into. Policy 19(3):255–265
- Sharma H, Chandra P, Pathak R, Bhandari M (2024) Advancements in the therapeutic approaches to treat neurological disorders. Cahiers Magellanes-Ns. 6(2):4328–89
- Sharma H, Anand A, Halagali P, Inamdar A, Pathak R, Taghizadeh-Hesary F, Ashique S (2024) Advancement of nanoengineered flavonoids for chronic metabolic diseases. Role Flav Chron Metabol Dis Bench Clin 18:459–510
- Prajapati C, Rai SN, Singh AK, Chopade BA, Singh Y, Singh SK et al (2025) An update of fungal endophyte diversity and strategies for augmenting therapeutic potential of their potent metabolites: recent advancement. Appl Biochem Biotechnol 5:1–68
- Kocik RA, Gasch AP (2022) Breadth and specificity in pleiotropic protein kinase A activity and environmental responses. Front Cell Dev Biol 10(February):1–11
- Wang H, Xu J, Lazarovici P, Quirion R, Zheng W (2018) cAMP response element-binding protein (CREB): a possible signaling molecule link in the pathophysiology of schizophrenia. Front Mol Neurosci 11(August):1–14
- Mehan S, Dudi R, Rajput M, Ghimire K (2018) Investigation of transcription factor cyclic AMP response element-binding protein activator in rodent model of intracerebral hemorrhage. Ann Clin Pharmacol Toxicol 1(1):ACPT-01-1003. https://www.medtextpublications.com/annals-of-clinical-pharmacology-toxicology-articles-in-press.php
- Chowdhury MAR, Haq MM, Lee JH, Jeong S (2024) Multi-faceted regulation of CREB family transcription factors. Front Mol Neurosci 17(August):1–18
- Sharma H, Al Noman A, Alam S, Tonni SD (2025) Plants as medicine for autism: reviewing the evidence for phytopharmaceuticals for ASD. Curr Bioact Compd 21:1–17. https://doi.org/10.2174/0115734072347775250129042526 · DOI
- Sanabra C, Mengod G (2011) Neuroanatomical distribution and neurochemical characterization of cells expressing adenylyl cyclase isoforms in mouse and rat brain. J Chem Neuroanat 41(1):43–54 · DOI · Paper page
- Maghsoudi S, Shuaib R, Van Bastelaere B, Dakshinamurti S (2024) Adenylyl cyclase isoforms 5 and 6 in the cardiovascular system: complex regulation and divergent roles. Front Pharmacol 15(April):1–23
- Giacoletti G, Price T, Hoelz LVB, Shremo Msdi A, Cossin S, Vazquez-Falto K et al (2022) A selective adenylyl cyclase 1 inhibitor relieves pain without causing tolerance. Front Pharmacol 13(July):1–12
- Guo R, Liu T, Shasaltaneh MD, Wang X, Imani S, Wen QL (2022) Targeting adenylate cyclase family: new concept of targeted cancer therapy. Front Oncol 12(June):1–15
- Sugo N, Morimatsu M, Arai Y, Kousoku Y, Ohkuni A, Nomura T et al (2014) Single-molecule imaging reveals dynamics of CREB transcription factor bound to its target sequence. Sci Rep 2015(5):1–9
- Sharma H, Halagali P, Majumder A, Sharma V, Pathak R (2024) Natural compounds targeting signaling pathways in breast cancer therapy. Afr J Biol Sci 6(10):5430–79
- Ida DJ& Y (2020) Journal of Population Therapeutics. ResearchgateNet [Internet]. 27(October):19–22. Available from: https://www.researchgate.net/profile/Amar-Thakare/publication/354153623_Arabian_undergraduates_perceptions_regarding_barriers_among_the_geriatric_patients_for_failing_to_keep_dental_appointments_A_cross-sectional_study/links/6127ef3d0360302a005f3b37/Arabi
- Pathak R, Sharma S, Bhandari M, Nogai L, Mishra R, Saxena A et al (2024) Neuroinflammation at the crossroads of metabolic and neurodegenerative diseases: causes, consequences and interventions. J Exp Zoology India 27(2):2447–2461
- Numakawa T, Kajihara R (2023) Involvement of brain-derived neurotrophic factor signaling in the pathogenesis of stress-related brain diseases. Front Mol Neurosci 16(September):1–15
- Schirò G, Iacono S, Ragonese P, Aridon P, Salemi G, Balistreri CR (2022) A brief overview on BDNF-Trk pathway in the nervous system: a potential biomarker or possible target in treatment of multiple sclerosis? Front Neurol 13(July):1–14
- Angelica MD, Fong Y (2008) Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity and disease. Dev Neurobiol 141(4):520–529
- Pradhan J, Noakes PG, Bellingham MC (2019) The role of altered BDNF/TrkB signaling in amyotrophic lateral sclerosis. Front Cell Neurosci 13(August):1–16
- Sharma H, Chandra P (2024) Effects of natural remedies on memory loss and Alzheimer’s disease. Afr J Biol Sci 6(7):187–211
- Zhang Z, Li H, Su Y, Ma J, Yuan Y, Yu Z et al (2022) Neuroprotective effects of a cholecystokinin analogue in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinson’s disease mouse model. Front Neurosci 16(March):1–14
- Sadek MA, Kandil EA, El Sayed NS, Sayed HM, Rabie MA (2022) Semaglutide, a novel glucagon-like peptide-1 agonist, amends experimental autoimmune encephalomyelitis-induced multiple sclerosis in mice: Involvement of the PI3K/Akt/GSK-3β pathway. Int Immunopharmacol 2023(115):109647
- Hassab LY, Abbas SS, Mohammed RA, Abdallah DM (2023) Dimethyl fumarate abrogates striatal endoplasmic reticulum stress in experimentally induced late-stage Huntington’s disease: focus on the IRE1α/JNK and PERK/CHOP trajectories. Front Pharmacol 14(March):1–13
- Rabie MA, Ibrahim HI, Nassar NN, Atef RM (2022) Adenosine A1 receptor agonist, N6-cyclohexyladenosine, attenuates Huntington’s disease via stimulation of TrKB/PI3K/Akt/CREB/BDNF pathway in 3-nitropropionic acid rat model. Chem Biol Interact 2023(369):110288
- Gong G, Ganesan K, Wang Y, Zhang Z, Liu Y, Wang J et al (2023) Ononin ameliorates depression-like behaviors by regulating BDNF-TrkB-CREB signaling in vitro and in vivo. J Ethnopharmacol 2024(320):117375
- Yang Z, Zhao Y, Wang Y, Liu X, Jiang Y, Jiang Y et al (2023) Echinacoside ameliorates post-stroke depression by activating BDNF signaling through modulation of Nrf2 acetylation. Phytomedicine 2024(128):155433
- Qian L, Huang S, Liu X, Jiang Y, Jiang Y, Hu Y et al (2023) Morroniside improves the symptoms of post-stroke depression in mice through the BDNF signaling pathway mediated by MiR-409-3p. Phytomedicine 2024(123):155224
- Liu SZ, Yang J, Chen LL, Wang P, Lin L (2022) Tanshinone IIA ameliorates chronic unpredictable mild stress-induced depression-like behavior and cognitive impairment in rats through the BDNF/TrkB/GAT1 signaling pathway. Eur J Pharmacol 2023(938):175385
- Zhang S, Hu Y, Zhao Y, Feng Y, Wang X, Miao M et al (2023) Molecular mechanism of Chang Shen Hua volatile oil modulating brain cAMP-PKA-CREB pathway to improve depression-like behavior in rats. Phytomedicine 2024(130):155729
- Mehan S, Kumar A, Sharma T (2024) Therapeutic efficacy of Genistein in activation of neuronal AC / cAMP / CREB / PKA and mitochondrial ETC-Complex pathways in experimental model of autism : evidence from CSF, blood plasma and brain analysis. Brain Res 2024(1846):149251
- Uutela M, Lindholm J, Rantamäki T, Umemori J, Hunter K, Võikar V et al (2014) Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome. Front Cell Neurosci 8(MAY):1–9
- Seese RR, Le AA, Wang K, Cox CD, Lynch G, Gall CM (2019) A TrkB agonist and ampakine rescue synaptic plasticity and multiple forms of memory in a mouse model of intellectual disability. Neurobiol Dis 2020(134):104604
- Günaydın C, Arslan G, Bilge SS (2019) Proconvulsant effect of trans-cinnamaldehyde in pentylenetetrazole-induced kindling model of epilepsy: the role of TRPA1 channels. Neurosci Lett 2020(721):134823
- Niu J, Cao Y, Ji Y (2020) Resveratrol, a SIRT1 activator, ameliorates MK-801-induced cognitive and motor impairments in a neonatal rat model of schizophrenia. Front Psychiatry 11(July):1–9
- Sharma H, Rachamalla HK, Mishra N, Chandra P, Pathak R, Ashique S (2024) Introduction to exosome and its role in brain disorders. Exosomes Based Drug Deliv Strat Brain Disord 31:1–35
- Sharma H, Rani T, Khan S (2023) An insight into neuropathic pain: a systemic and up-to-date review. Int J Pharm Sci Res 14(2):607–21
Cited by
Lutfy, R. H., Ashour, A. M., Khames, A., Elhemiely, A. A., Alam-ElDein, K. M., Faraag, A. H. I., Hamed, M. O. A., Daim, Z. J. A., Attia, N. I., & Gadelmawla, M. H. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211173 · Cited by 30
Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging
Goel, F., Singh, P., Nand, S., & Yadav, D. K. (2026) · 3 Biotech · doi:10.1007/s13205-025-04673-z · Cited by 26
α7 nicotinic acetylcholine receptor and depression: Mechanistic insights and therapeutic prospects
Wang, C., Gan, D., Hong, Z., Feng, H., Wu, Y., Xu, G., Xun, T., & Yang, X. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107122 · Cited by 8
Molecular mechanisms underlying obesity-induced memory dysfunction: a comprehensive narrative review
Golkar, A., Razazpour, F., Dalfardi, M., & Baghcheghi, Y. (2025) · Physiology & Behavior · doi:10.1016/j.physbeh.2025.115119 · Cited by 8
Mvelase, Z., Luvuno, M., & Mabandla, M. V. (2025) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2025.100256 · Cited by 7
Metadata
- Authors
- Gupta, A. K., Gupta, S., Mehan, S., Khan, Z., Das Gupta, G., & Narula, A. S.
- Affiliations
- Punjab Technical University (IN)
- Indo Soviet Friendship College of Pharmacy (IN)
- Corresponding author
- Mehan, Sidharth
- Venue
- Molecular Neurobiology
- Published
- 2025-05-09
- Volume
- 62
- Issue
- 11
- Pages
- 14627-14659
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W4410196581
- Cited by
- 59
- References
- 217
- Citations by year
- 2026: 46 · 2025: 12
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science and Engineering Research Board (DST-SERB, CRG (Core Research Grant), Grant Number: CRG/2021/001009)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- BDNF/TrkB signaling, neuroprotection, neurodegenerative diseases, neuropsychiatric disorders, neuroplasticity, adenylate cyclase, cyclic AMP, protein kinase A, CREB, nanoparticle drug delivery, gene therapy, blood-brain barrier, cognitive resilience
- MeSH terms
- Neuroprotection, Cyclic AMP, Adenylyl Cyclases, Animals, Humans, Nervous System Diseases, Signal Transduction, Cyclic AMP Response Element-Binding Protein, Cyclic AMP-Dependent Protein Kinases, Brain-Derived Neurotrophic Factor, Receptor, trkB
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exploring the Connection Between BDNF/TrkB and AC/cAMP/PKA/CREB Signaling Pathways: Potential for Neuroprotection and Therapeutic Targets for Neurological Disorders. https://app.cochat.ai/papers/10.1007/s12035-025-05001-5
- The paper
- Gupta, A. K., Gupta, S., Mehan, S., Khan, Z., Das Gupta, G., & Narula, A. S. (2025). Exploring the Connection Between BDNF/TrkB and AC/cAMP/PKA/CREB Signaling Pathways: Potential for Neuroprotection and Therapeutic Targets for Neurological Disorders. Molecular Neurobiology. https://doi.org/10.1007/s12035-025-05001-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.